Cargando…

Postoperative Femoral Nerve Palsy and Meralgia Paresthetica after Gynecologic Oncologic Surgery

Femoral nerve palsy and meralgia paresthetica following gynecologic cancer surgery are rare, but severe and long lasting. Here, we aimed to study their incidence, severity, possible risk factors and its time to remission. Between January 2008 and December 2017 976 gynecologic cancer patients were id...

Descripción completa

Detalles Bibliográficos
Autores principales: Egger, Eva Katharina, Sezer, Oezge, Condic, Mateja, Recker, Florian, Marinova, Milka, Hilbert, Tobias, Koscielny, Arne, Mustea, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655817/
https://www.ncbi.nlm.nih.gov/pubmed/36362470
http://dx.doi.org/10.3390/jcm11216242
_version_ 1784829279575474176
author Egger, Eva Katharina
Sezer, Oezge
Condic, Mateja
Recker, Florian
Marinova, Milka
Hilbert, Tobias
Koscielny, Arne
Mustea, Alexander
author_facet Egger, Eva Katharina
Sezer, Oezge
Condic, Mateja
Recker, Florian
Marinova, Milka
Hilbert, Tobias
Koscielny, Arne
Mustea, Alexander
author_sort Egger, Eva Katharina
collection PubMed
description Femoral nerve palsy and meralgia paresthetica following gynecologic cancer surgery are rare, but severe and long lasting. Here, we aimed to study their incidence, severity, possible risk factors and its time to remission. Between January 2008 and December 2017 976 gynecologic cancer patients were identified in our institutional database receiving surgery. Complete patient charts were reviewed retrospectively. Possible risk factors were analyzed by Fisher’s exact test. 441 (45.18%) out 976 were treated for Ovarian cancer. In total 23 patients were identified with a postoperative neurological leg disorder. A femoral nerve palsy was present in 15 patients (1.5%) and a meralgia paresthetica in 8 patients (0.82%). Three patients showed both disorders. Duration of surgery (p = 0.0000), positioning during surgery (p = 0.0040), femoral artery catheter (p = 0.0051), prior chemotherapy (p = 0.0007), nicotine abuse (p = 0.00456) and prior polyneuropathy (p = 0.0181) showed a significant association with a postoperative femoral nerve palsy. Nicotine abuse (p = 0.0335) and prior chemotherapy (p = 0.0151) were significant for the development of a meralgia paresthetica. Long lasting surgery, patient positioning and femoral arterial catheter placement are risk factors for a postoperative femoral nerve palsy in gynecologic cancer surgery. Polyneuropathy, nicotine abuse, and prior chemotherapy are predisposing risk factors for a femoral nerve palsy and a meralgia paresthetica. A resolution of symptoms is the rule for both disorders within different time schedules.
format Online
Article
Text
id pubmed-9655817
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96558172022-11-15 Postoperative Femoral Nerve Palsy and Meralgia Paresthetica after Gynecologic Oncologic Surgery Egger, Eva Katharina Sezer, Oezge Condic, Mateja Recker, Florian Marinova, Milka Hilbert, Tobias Koscielny, Arne Mustea, Alexander J Clin Med Article Femoral nerve palsy and meralgia paresthetica following gynecologic cancer surgery are rare, but severe and long lasting. Here, we aimed to study their incidence, severity, possible risk factors and its time to remission. Between January 2008 and December 2017 976 gynecologic cancer patients were identified in our institutional database receiving surgery. Complete patient charts were reviewed retrospectively. Possible risk factors were analyzed by Fisher’s exact test. 441 (45.18%) out 976 were treated for Ovarian cancer. In total 23 patients were identified with a postoperative neurological leg disorder. A femoral nerve palsy was present in 15 patients (1.5%) and a meralgia paresthetica in 8 patients (0.82%). Three patients showed both disorders. Duration of surgery (p = 0.0000), positioning during surgery (p = 0.0040), femoral artery catheter (p = 0.0051), prior chemotherapy (p = 0.0007), nicotine abuse (p = 0.00456) and prior polyneuropathy (p = 0.0181) showed a significant association with a postoperative femoral nerve palsy. Nicotine abuse (p = 0.0335) and prior chemotherapy (p = 0.0151) were significant for the development of a meralgia paresthetica. Long lasting surgery, patient positioning and femoral arterial catheter placement are risk factors for a postoperative femoral nerve palsy in gynecologic cancer surgery. Polyneuropathy, nicotine abuse, and prior chemotherapy are predisposing risk factors for a femoral nerve palsy and a meralgia paresthetica. A resolution of symptoms is the rule for both disorders within different time schedules. MDPI 2022-10-22 /pmc/articles/PMC9655817/ /pubmed/36362470 http://dx.doi.org/10.3390/jcm11216242 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Egger, Eva Katharina
Sezer, Oezge
Condic, Mateja
Recker, Florian
Marinova, Milka
Hilbert, Tobias
Koscielny, Arne
Mustea, Alexander
Postoperative Femoral Nerve Palsy and Meralgia Paresthetica after Gynecologic Oncologic Surgery
title Postoperative Femoral Nerve Palsy and Meralgia Paresthetica after Gynecologic Oncologic Surgery
title_full Postoperative Femoral Nerve Palsy and Meralgia Paresthetica after Gynecologic Oncologic Surgery
title_fullStr Postoperative Femoral Nerve Palsy and Meralgia Paresthetica after Gynecologic Oncologic Surgery
title_full_unstemmed Postoperative Femoral Nerve Palsy and Meralgia Paresthetica after Gynecologic Oncologic Surgery
title_short Postoperative Femoral Nerve Palsy and Meralgia Paresthetica after Gynecologic Oncologic Surgery
title_sort postoperative femoral nerve palsy and meralgia paresthetica after gynecologic oncologic surgery
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655817/
https://www.ncbi.nlm.nih.gov/pubmed/36362470
http://dx.doi.org/10.3390/jcm11216242
work_keys_str_mv AT eggerevakatharina postoperativefemoralnervepalsyandmeralgiaparestheticaaftergynecologiconcologicsurgery
AT sezeroezge postoperativefemoralnervepalsyandmeralgiaparestheticaaftergynecologiconcologicsurgery
AT condicmateja postoperativefemoralnervepalsyandmeralgiaparestheticaaftergynecologiconcologicsurgery
AT reckerflorian postoperativefemoralnervepalsyandmeralgiaparestheticaaftergynecologiconcologicsurgery
AT marinovamilka postoperativefemoralnervepalsyandmeralgiaparestheticaaftergynecologiconcologicsurgery
AT hilberttobias postoperativefemoralnervepalsyandmeralgiaparestheticaaftergynecologiconcologicsurgery
AT koscielnyarne postoperativefemoralnervepalsyandmeralgiaparestheticaaftergynecologiconcologicsurgery
AT musteaalexander postoperativefemoralnervepalsyandmeralgiaparestheticaaftergynecologiconcologicsurgery